论文部分内容阅读
Pancreatic adenocarcinoma and hepatocellular carcinoma are devastating human malignancies that are characterized by poor prognosis,late onset,and a lack of known biomarkers.New diagnostic and therapeutic molecular targets are desperately needed to develop